Evidence map›Paper›PMID 42796746›Full record

ReviewPathogens (Basel, Switzerland)2026

A Biological Approach to Antimicrobial Resistance in New and Old Bacterial Pathogens.

Robert J Atterbury, Adriano M Gigante, Paul A Barrow

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Robert J AtterburySchool of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington Campus, Sutton Bonington, Leicestershire LE12 5RD, UK.ORCID 0000-0002-9698-7748
Adriano M GiganteSchool of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington Campus, Sutton Bonington, Leicestershire LE12 5RD, UK.ORCID 0000-0003-4190-0227
Paul A BarrowSchool of Veterinary Medicine, University of Surrey, Daphne Jackson Road, Guildford GU2 7AL, UK.ORCID 0000-0002-5607-0599

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistance to antimicrobials in bacterial pathogens has become a major global public health issue that international institutions are now realizing must be tackled with a degree of urgency. A major issue is the self-transmissibility of the plasmids that carry most of the resistance genes. Scientists are now exploring ways in which the antimicrobial resistance plasmids might be tackled directly to reduce resistance. Pharmacological approaches to destabilizing plasmids have not yet been tested in vivo. Phagemids may be used to introduce genes which harm the bacteria themselves or disrupt key plasmid genes. The transfer of transmissible plasmids is mediated by thin conjugative pili which are also attachment sites for a range of lytic bacteriophages. Such phages may be used to kill bacterial cultures where fimbriae are highly de-repressed. They also select for the small number of bacterial cells which have spontaneously lost their plasmid, thereby replacing an antibiotic-resistant strain with one which is once again fully susceptible to antibiotics. This has been demonstrated both in vitro and in animal models of infection. A pharmaceutical approach is proposed to de-repress the plasmids possessed by many strains and thereby increase phage susceptibility.

Indexed as

Anti-Bacterial AgentsBacteriaBacterial InfectionsDrug Resistance, BacterialAnimalsBacteriophagesHumansPlasmidsAnti-Bacterial Agentsantibiotic resistanceantibioticsantimicrobial resistancebacteriophageplasmid

Identifiers

PMID42796746
PMCPMC13610592

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.